scholarly article | Q13442814 |
P50 | author | Elaine Mardis | Q5353251 |
Stephen P Hunger | Q64215088 | ||
Mignon L Loh | Q64215090 | ||
Ching-Hon Pui | Q66385450 | ||
Sima Jeha | Q100677736 | ||
Meenakshi Devidas | Q102141953 | ||
Deqing Pei | Q114529747 | ||
Elizabeth A Raetz | Q114529750 | ||
P2093 | author name string | Robert S Fulton | |
Mary V Relling | |||
Chengcheng Liu | |||
William E Evans | |||
Cheng Cheng | |||
Wenjian Yang | |||
Naomi J Winick | |||
William L Carroll | |||
W Paul Bowman | |||
Scott C Howard | |||
Paul L Martin | |||
Deepa Bhojwani | |||
Kelly W Maloney | |||
Leonard A Mattano | |||
Colton Smith | |||
Eric C Larsen | |||
P2860 | cites work | Mutations in DHDPSL Are Responsible For Primary Hyperoxaluria Type III | Q24297629 |
Primary hyperoxaluria type III gene HOGA1 (formerly DHDPSL) as a possible risk factor for idiopathic calcium oxalate urolithiasis | Q24337342 | ||
Treating childhood acute lymphoblastic leukemia without cranial irradiation | Q24644599 | ||
Chymotrypsin C (caldecrin) promotes degradation of human cationic trypsin: identity with Rinderknecht's enzyme Y | Q24675338 | ||
A novel mutation of the calcium sensing receptor gene is associated with chronic pancreatitis in a family with heterozygous SPINK1 mutations | Q24805119 | ||
Mutations in the gene encoding the serine protease inhibitor, Kazal type 1 are associated with chronic pancreatitis | Q28145585 | ||
Common genetic variants in the CLDN2 and PRSS1-PRSS2 loci alter risk for alcohol-related and sporadic pancreatitis | Q30528817 | ||
Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91-01. | Q32061751 | ||
Drug-induced pancreatitis: an update | Q33221158 | ||
Long-term results of Dana-Farber Cancer Institute ALL Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1985-2000). | Q33645760 | ||
The sequence and conformation of human pancreatic procarboxypeptidase A2. cDNA cloning, sequence analysis, and three-dimensional model. | Q34321392 | ||
American College of Gastroenterology guideline: management of acute pancreatitis | Q34360523 | ||
Ancestry and pharmacogenomics of relapse in acute lymphoblastic leukemia | Q35015010 | ||
Combined bicarbonate conductance-impairing variants in CFTR and SPINK1 variants are associated with chronic pancreatitis in patients without cystic fibrosis | Q35209665 | ||
Protective effect of a microtubule stabilizer taxol on caerulein-induced acute pancreatitis in rat. | Q35596569 | ||
Results of the Dana-Farber Cancer Institute ALL Consortium Protocol 95-01 for children with acute lymphoblastic leukemia | Q35616085 | ||
Metabolism of [13C5]hydroxyproline in vitro and in vivo: implications for primary hyperoxaluria. | Q35849447 | ||
Prognostic significance of minimal residual disease in high risk B-ALL: a report from Children's Oncology Group study AALL0232. | Q35976588 | ||
Predicting asparaginase-associated pancreatitis | Q36579699 | ||
Postinduction dexamethasone and individualized dosing of Escherichia Coli L-asparaginase each improve outcome of children and adolescents with newly diagnosed acute lymphoblastic leukemia: results from a randomized study--Dana-Farber Cancer Institut | Q36678136 | ||
Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study | Q36713493 | ||
Sequence kernel association tests for the combined effect of rare and common variants | Q36909285 | ||
Variants in CPA1 are strongly associated with early onset chronic pancreatitis | Q37540036 | ||
The role of calcium in acute pancreatitis | Q38036042 | ||
Asparaginase-associated pancreatitis in children | Q38036389 | ||
Genetics of acute and chronic pancreatitis | Q38122993 | ||
Association of oral glucocorticoid use with an increased risk of acute pancreatitis: a population-based nested case-control study | Q38427548 | ||
Mutations of the cystic fibrosis gene in patients with chronic pancreatitis | Q38502091 | ||
Pegaspargase-induced pancreatitis | Q41722320 | ||
Pancreatic exocrine secretion in acute experimental pancreatitis | Q42485711 | ||
HLA-DQA1-HLA-DRB1 variants confer susceptibility to pancreatitis induced by thiopurine immunosuppressants. | Q42704205 | ||
A randomized comparison of native Escherichia coli asparaginase and polyethylene glycol conjugated asparaginase for treatment of children with newly diagnosed standard-risk acute lymphoblastic leukemia: a Children's Cancer Group study | Q43904527 | ||
Improved outcome for children with acute lymphoblastic leukemia: results of Total Therapy Study XIIIB at St Jude Children's Research Hospital | Q44976795 | ||
Incidence and outcome of pancreatitis in children and young adults with acute lymphoblastic leukaemia treated on a contemporary protocol, UKALL 2003. | Q46540888 | ||
Augmented post-remission therapy for a minimal residual disease-defined high-risk subgroup of children and young people with clinical standard-risk and intermediate-risk acute lymphoblastic leukaemia (UKALL 2003): a randomised controlled trial. | Q50670242 | ||
Latent onset of clinical pancreatitis in children receiving l-asparaginase therapy | Q53775952 | ||
Mutations in the calcium-sensing receptor: A new genetic risk factor for chronic pancreatitis? | Q60689172 | ||
Acute pancreatitis in children with acute lymphoblastic leukemia treated with L-asparaginase | Q84577211 | ||
6-Mercaptopurine-induced recurrent acute pancreatitis in children with acute lymphoblastic leukemia/lymphoma | Q85396912 | ||
Asparaginase-associated pancreatitis in children with acute lymphoblastic leukaemia in the NOPHO ALL2008 protocol | Q87104417 | ||
P433 | issue | 18 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | leukemia | Q29496 |
acute pancreatitis | Q854573 | ||
P304 | page(s) | 2133-2140 | |
P577 | publication date | 2016-04-25 | |
P1433 | published in | Journal of Clinical Oncology | Q400292 |
P1476 | title | Clinical and Genetic Risk Factors for Acute Pancreatitis in Patients With Acute Lymphoblastic Leukemia | |
P478 | volume | 34 |
Q38665804 | Asparaginase-associated pancreatitis in childhood acute lymphoblastic leukaemia: an observational Ponte di Legno Toxicity Working Group study |
Q51620499 | Asparaginase-associated pancreatitis: a study on phenotype and genotype in the NOPHO ALL2008 protocol. |
Q92672135 | Asparagine Synthetase Is Highly Expressed at Baseline in the Pancreas Through Heightened PERK Signaling |
Q47792311 | Crisis management in the treatment of childhood acute lymphoblastic leukemia: putting right what can go wrong (emergency complications of disease and treatment). |
Q64244287 | Fed-Batch Production of L-Asparaginase II by Recombinant Strain |
Q39262358 | Genome-Wide Association Studies of Chemotherapeutic Toxicities: Genomics of Inequality |
Q46377291 | Genomewide Approach Validates Thiopurine Methyltransferase Activity Is a Monogenic Pharmacogenomic Trait. |
Q91249010 | Global efforts toward the cure of childhood acute lymphoblastic leukaemia |
Q38968891 | In silico frameworks for systematic pre-clinical screening of potential anti-leukemia therapeutics |
Q99616292 | Increasing completion of asparaginase treatment in childhood acute lymphoblastic leukaemia (ALL): summary of an expert panel discussion |
Q33557148 | Non-infectious chemotherapy-associated acute toxicities during childhood acute lymphoblastic leukemia therapy. |
Q102068310 | Peg-Asparaginase-Associated Pancreatitis in Chemotherapy-Treated Pediatric Patients: A 5-Year Retrospective Study |
Q45985775 | Predictors of hepatotoxicity and pancreatitis in children and adolescents with acute lymphoblastic leukemia treated according to contemporary regimens. |
Q50200720 | Questions on asparaginase-associated pancreatitis |
Q90463690 | Somatic and germline genomics in paediatric acute lymphoblastic leukaemia |
Q38922016 | Treatment of Childhood Acute Lymphoblastic Leukemia: Prognostic Factors and Clinical Advances |
Q64077397 | Trypsin-encoding variations influence the risk of asparaginase-associated pancreatitis in children with acute lymphoblastic leukemia: a Ponte di Legno toxicity working group report |
Q38748699 | Whole-exome sequencing identified genetic risk factors for asparaginase-related complications in childhood ALL patients |
Search more.